Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02084147 · ClinicalTrials.gov registry record · NA
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT02084147 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 72 participants.
The verdict
NCT02084147, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies how well positron emission tomography (PET)-magnetic resonance imaging (MRI) works compared to standard-of-care PET-computed tomography (CT) in diagnosing patients with cancer, cardiac diseases, or neurologic diseases. PET-MRI combines two imaging methods that can be used to evaluate disease. PET-MRI is similar to standard-of-care PET-CT, but exposes the patient to less radiation. It is not yet known whether PET-MRI produces better image quality than PET-CT in diagnosing patients with cancer, cardiac disease, or neurologic disease.
Interventions
- DEVICE computed tomography
- DEVICE positron emission tomography
- DEVICE magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2013-03-07 |
| Est. Completion | 2018-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02084147
The ClinicalTrials.gov registry entry for NCT02084147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which computed tomography is the first listed.
NCT02084147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02084147 about?
NCT02084147 is a clinical study titled "PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases". This randomized pilot clinical trial studies how well positron emission tomography (PET)-magnetic resonance imaging (MRI) works compared to standard-of-care PET-computed tomography (CT) in diagnosing patients with cancer, cardiac diseases, or neurologic diseases. PET-MRI combines two imaging methods...
What is the current status of trial NCT02084147?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2013-03-07. Estimated completion is 2018-10-02.
What interventions are being tested in trial NCT02084147?
The interventions under investigation include: computed tomography (DEVICE), positron emission tomography (DEVICE), magnetic resonance imaging (DEVICE).
Who is sponsoring clinical trial NCT02084147?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.